TRPV4 and Hydrocephalus: Antagonists to the transient receptor potential vanilloid 4 (TRPV4), a gated divalent cation channel highly expressed by choroid plexus [84], have also been proposed as a treatment for hydrocephalus [85], but there are no published data supporting the concept.